Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat Intranodal Ad-ISF35 in CLL/SLL
NCT00849524Phase 2Terminated
- Start
- Jan 2009
- Primary completion
- Jul 2009
- Modality
- Gene Editing, Gene Silencing, Adenoviral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of ISF35 in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL). Started Jan 2009; status: terminated.
02
Drugs
ISF35
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00849524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849524.